ENTITY
Hangzhou Tigermed Consulting C

Hangzhou Tigermed Consulting C (3347 HK)

106
Analysis
Health CareChina
Hangzhou Tigermed Consulting Co.,Ltd. provides professional clinical research services for domestic and foreign pharmaceutical and health-related research and development. The Company's main services include clinical trial technology services, data management, and statistical analysis. Hangzhou Tigermed Consulting offers services worldwide.
more
Refresh
17 Sep 2020 01:38

JHBP Holdings (Genor Biopharma) IPO Initiation: Hunting for a Cure

$ Genor Biopharma is a biopharmaceutical company focusing on developing and commercializing oncology and autoimmune drugs. Its drug candidates...

Logo
443 Views
Share
bullishKE Holdings
09 Aug 2020 12:19

ECM Weekly (9 August 2020) - KE Holdings, Pop Mart, Everest Med, KWG Living, E-Star Comm

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Hong...

Share
06 Aug 2020 14:57

Tigermed IPO: Trading Debut

Hangzhou Tigermed Consulting (H) (3347 HK) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...

Logo
405 Views
Share
06 Aug 2020 11:51

Tigermed (泰格医疗) A+H Trading: Insti Buying to Continue Post Listing

Hangzhou Tigermed raised HKD 10,272 million (USD 1.3 bn) from its global offering and will list on the Hong Kong Stock Exchange tomorrow. In our...

Logo
385 Views
Share
02 Aug 2020 18:28

Haier Electronics’ Privatisation Bid from Haier Smart Home

After market close on Friday, Haier Electronics Group Co (1169 HK)/HEG announced a pre-conditional privatisation offer by way of a scheme of...

Logo
462 Views
Share
x